2
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| neuroendocrine carcinoma | a humanized bispecific monoclonal antibody against PD-L1 and 4-1BB | Orphan Designation | - |
| plasma cell myeloma | a bispecific antibody targeting the G protein-coupled receptor class C group 5 member D (GPRC5D) and a cluster of differentiation 3 (CD3) | Orphan Designation | - |